Published February 2, 2023
By Ben Adlin
OG Article: here.
View our Fair Use Policy: here.
A new study, led by researchers at New York’s Department of Health and published this week by the American Medical Association, found that chronic pain patients who received medical marijuana for longer than a month saw significant reductions in prescribed opioids.
The analysis looked at data from more than 8,000 patients registered in New York’s medical cannabis program, tracking how their opioid prescriptions changed over time. It concluded that among pain patients who received marijuana for more than 30 days, opioid amounts fell by nearly half.
New York’s acting health commissioner, James McDonald, called the study “further evidence that medical cannabis has the potential to reduce the amount of opioid-based medications needed to treat chronic pain.”